Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.35 USD
Change Today -0.34 / -1.04%
Volume 347.5K
ZLTQ On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

zeltiq aesthetics inc (ZLTQ) Snapshot

Open
$32.70
Previous Close
$32.69
Day High
$33.31
Day Low
$32.30
52 Week High
02/6/15 - $35.90
52 Week Low
07/10/14 - $13.30
Market Cap
1.2B
Average Volume 10 Days
352.6K
EPS TTM
$0.02
Shares Outstanding
38.5M
EX-Date
--
P/E TM
1,617.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ZELTIQ AESTHETICS INC (ZLTQ)

zeltiq aesthetics inc (ZLTQ) Related Bloomberg News

View More Bloomberg News

zeltiq aesthetics inc (ZLTQ) Related Businessweek News

No Related Businessweek News Found

zeltiq aesthetics inc (ZLTQ) Details

ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled cooling technology to selectively reduce stubborn fat bulges. ZELTIQ Aesthetics, Inc. sells its products through a direct sales force, as well as through a network of distributors to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.

408 Employees
Last Reported Date: 03/10/15
Founded in 2005

zeltiq aesthetics inc (ZLTQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $875.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $449.5K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $552.5K
Senior Vice President, General Legal Counsel ...
Total Annual Compensation: $351.9K
Compensation as of Fiscal Year 2013.

zeltiq aesthetics inc (ZLTQ) Key Developments

ZELTIQ Aesthetics, Inc. Showcases New CoolSmooth PRO Applicator at American Academy of Dermatology Annual Meeting

ZELTIQ Aesthetics, Inc. announced it is showcasing its CoolSmooth PRO applicator, a second generation surface applicator featuring non-vacuum based cooling to treat non-pinchable fat bulges such as the outer thigh area, at the American Academy of Dermatology Annual Meeting in San Francisco, March 20-24, 2015. Earlier this year the company received Food and Drug Administration (FDA) clearance to perform the CoolSculpting® procedure at lower temperatures, enabling shorter treatment times. The new treatment parameters are initially being offered with the CoolSmooth PRO applicator, which also includes an enhanced strapping system that provides increased conformity at the treatment site, while also improving ease of use and patient comfort. ZELTIQ plans to offer current CoolSmooth customers an exchange program to facilitate access to the new technology.

ZELTIQ Aesthetics, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Twelve Months Ended December 31, 2014; Revised Financial Guidance for the Full Year 2015

ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the fourth quarter and twelve months ended December 31, 2014. For the quarter, the company reported revenue of USD 50.772 million compared to USD 35.841 million a year ago. Income from operations was USD 1.607 million compared to loss from operations of USD 5.305 million a year ago. Income before income taxes was USD 1.535 million compared to loss before income taxes of USD 5.344 million a year ago. Net income was USD 1.317 million compared to net loss of USD 5.405 million a year ago. Basic and diluted net income per share was USD 0.03 compared to basic and diluted loss per share of USD 0.15 a year ago. Adjusted net income was USD 3.118 million compared to USD 3.121 million a year ago. Adjusted EBITDA was USD 4.435 million compared to adjusted LBITDA of USD 2.284 million a year ago. For the twelve months, the company reported revenue of USD 174.478 million compared to USD 111.626 million a year ago. Income from operations was USD 2.124 million compared to loss from operations of USD 19.348 million a year ago. Income before income taxes was USD 1.762 million compared to loss before income taxes of USD 19.165 million a year ago. Net income was USD 1.531 million compared to net loss of USD 19.305 million a year ago. Basic and diluted net income per share was USD 0.04 compared to basic and diluted loss per share of USD 0.53 a year ago. Net cash used in operating activities were USD 0.856 million compared to USD 4.081 million a year ago. Purchase of investments was USD 13.444 million compared to USD 31.591 million a year ago. Adjusted net income was USD 11.800 million compared to USD 8.346 million a year ago. Adjusted EBITDA was USD 13.331 million compared to adjusted LBITDA of USD 10.959 million a year ago. The company revised financial guidance for the full year of 2015. The company increased 2015 revenue guidance in the range of USD 230 million to USD 235 million or approximately 35% growth year-over-year. The company expects gross profit margin of approximately 71% of total revenue, stock-based compensation, depreciation, and amortization expense of approximately 7% of total revenue and adjusted EBITDA margin in the range of 7% to 8% of total revenue. In order to help bridge to adjusted EBITDA metric, the company is following expenses: depreciation and amortization of approximately USD 3 million.

ZELTIQ Aesthetics, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 10:30 AM

ZELTIQ Aesthetics, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 10:30 AM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Patrick F. Williams, Chief Financial Officer, Principal Accounting Officer and Senior Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZLTQ:US $32.35 USD -0.34

ZLTQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cynosure Inc $33.91 USD +0.02
El.En. SpA €37.90 EUR -0.17
Lutronic Corp 37,200 KRW -250.00
PhotoMedex Inc $2.18 USD +0.13
Syneron Medical Ltd $12.23 USD +0.18
View Industry Companies
 

Industry Analysis

ZLTQ

Industry Average

Valuation ZLTQ Industry Range
Price/Earnings 100.0x
Price/Sales 7.1x
Price/Book 17.7x
Price/Cash Flow 821.0x
TEV/Sales 6.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZELTIQ AESTHETICS INC, please visit www.coolsculpting.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.